The role of hypoxia in the regulation of serotonergic signaling: an investigation of HTR1B and TPH-1 expression in colorectal cancer and C. elegans models
摘要
Serotonin (5-Hydroxytryptamine, 5-HT) is a crucial monoamine, synthesized from L-tryptophan by the enzyme tryptophan hydroxylase (TPH). Serotonin exerts its diverse effects through membrane-bound serotonin receptors. Evidence suggests that 5-HT plays a potential role in cancer biology, influencing proliferation, invasion, metastasis, and angiogenesis in tumors. Specifically, receptors such as 5 − HT1A, 5 − HT1B, 5 − HT1D, and 5 − HT2A have been investigated in various cancers; however, their precise influence in colorectal cancer (CRC) remains poorly understood. Tumor cells exhibit high energy consumption due to uncontrolled division, leading to a hypoxic condition within the tumor microenvironment (TME). This hypoxic TME is a key driver of altered gene regulation. This study investigated the alterations in the expression of the HTR1B (encoding 5 − HT1B receptor) and TPH1 genes in CRC cell models under hypoxic conditions at both the mRNA and protein levels. Furthermore, the expression of the orthologous genes, ser − 4 and cTPH, was examined in the model organism C.elegans under hypoxic conditions. Bioinformatics analysis revealed an 87% homology between these two genes, indicating shared cellular signaling pathways. Experimental results revealed distinct, time-dependent regulatory patterns. In SW-480 cells, a biphasic response was observed, with both HTR1B mRNA and protein levels decreasing at 24 h followed by a significant upregulation at 48–72 h. In HT-29 cells, HTR1B mRNA was induced at 24 h before declining, while protein levels showed a sustained increase up to 72 h. In HUVEC cells, although mRNA levels decreased at 24 h, protein expression increased significantly at the same time point, suggesting post-transcriptional stabilization. In C. elegans, mRNA levels of the orthologous genes were significantly upregulated at 1 h of hypoxia. These findings demonstrate that hypoxia remodels the serotonergic system in a cell-line and time-specific manner. The consistent upregulation of HTR1B across different models highlights its potential as a mechanistically-relevant biomarker and a target for anti-cancer strategies.